vs

Side-by-side financial comparison of BALCHEM CORP (BCPC) and IDEX Corporation (IEX). Click either name above to swap in a different company.

IDEX Corporation is the larger business by last-quarter revenue ($398.4M vs $270.7M, roughly 1.5× BALCHEM CORP). IDEX Corporation runs the higher net margin — 30.1% vs 14.9%, a 15.2% gap on every dollar of revenue. On growth, IDEX Corporation posted the faster year-over-year revenue change (16.7% vs 8.1%). IDEX Corporation produced more free cash flow last quarter ($86.0M vs $33.8M). Over the past eight quarters, BALCHEM CORP's revenue compounded faster (7.5% CAGR vs -29.4%).

Balchem Corp is a global specialty chemicals and nutritional ingredients provider that develops, manufactures and distributes application-specific products for human nutrition, animal health, pharmaceutical and industrial end markets, serving customers across North America, Europe and Asia Pacific.

IDEX can refer to several things, including:International Defence Exhibition, a biennial arms and defense technology sales exhibition IDEX Corporation, a publicly listed company that makes fluidics systems and specialty engineered products Ideanomics, a publicly traded company that trades under the IDEX ticker symbol.

BCPC vs IEX — Head-to-Head

Bigger by revenue
IEX
IEX
1.5× larger
IEX
$398.4M
$270.7M
BCPC
Growing faster (revenue YoY)
IEX
IEX
+8.6% gap
IEX
16.7%
8.1%
BCPC
Higher net margin
IEX
IEX
15.2% more per $
IEX
30.1%
14.9%
BCPC
More free cash flow
IEX
IEX
$52.2M more FCF
IEX
$86.0M
$33.8M
BCPC
Faster 2-yr revenue CAGR
BCPC
BCPC
Annualised
BCPC
7.5%
-29.4%
IEX

Income Statement — Q1 FY2026 vs Q2 FY2026

Metric
BCPC
BCPC
IEX
IEX
Revenue
$270.7M
$398.4M
Net Profit
$40.3M
$120.0M
Gross Margin
99.9%
Operating Margin
20.5%
43.3%
Net Margin
14.9%
30.1%
Revenue YoY
8.1%
16.7%
Net Profit YoY
8.7%
25.7%
EPS (diluted)
$1.25
$1.61

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BCPC
BCPC
IEX
IEX
Q2 26
$398.4M
Q1 26
$270.7M
$407.7M
Q4 25
$263.6M
$899.1M
Q3 25
$267.6M
$878.7M
Q2 25
$255.5M
$865.4M
Q1 25
$250.5M
$814.3M
Q4 24
$240.0M
$862.9M
Q3 24
$239.9M
$798.2M
Net Profit
BCPC
BCPC
IEX
IEX
Q2 26
$120.0M
Q1 26
$40.3M
$128.3M
Q4 25
$39.2M
$128.3M
Q3 25
$40.3M
$127.8M
Q2 25
$38.3M
$131.6M
Q1 25
$37.1M
$95.5M
Q4 24
$33.6M
$123.2M
Q3 24
$33.8M
$119.1M
Gross Margin
BCPC
BCPC
IEX
IEX
Q2 26
99.9%
Q1 26
94.9%
Q4 25
35.6%
43.1%
Q3 25
35.7%
44.5%
Q2 25
36.4%
45.3%
Q1 25
35.2%
45.3%
Q4 24
36.0%
42.5%
Q3 24
35.6%
44.3%
Operating Margin
BCPC
BCPC
IEX
IEX
Q2 26
43.3%
Q1 26
20.5%
45.0%
Q4 25
19.8%
20.4%
Q3 25
20.4%
21.1%
Q2 25
20.1%
21.7%
Q1 25
20.4%
17.4%
Q4 24
19.8%
19.2%
Q3 24
20.0%
21.0%
Net Margin
BCPC
BCPC
IEX
IEX
Q2 26
30.1%
Q1 26
14.9%
31.5%
Q4 25
14.9%
14.3%
Q3 25
15.1%
14.5%
Q2 25
15.0%
15.2%
Q1 25
14.8%
11.7%
Q4 24
14.0%
14.3%
Q3 24
14.1%
14.9%
EPS (diluted)
BCPC
BCPC
IEX
IEX
Q2 26
$1.61
Q1 26
$1.25
$1.71
Q4 25
$1.21
$1.71
Q3 25
$1.24
$1.70
Q2 25
$1.17
$1.74
Q1 25
$1.13
$1.26
Q4 24
$1.03
$1.61
Q3 24
$1.03
$1.57

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BCPC
BCPC
IEX
IEX
Cash + ST InvestmentsLiquidity on hand
$72.9M
$586.2M
Total DebtLower is stronger
Stockholders' EquityBook value
$1.3B
$4.0B
Total Assets
$1.7B
$6.9B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BCPC
BCPC
IEX
IEX
Q2 26
$586.2M
Q1 26
$72.9M
$580.0M
Q4 25
$74.6M
$580.0M
Q3 25
$65.1M
$593.8M
Q2 25
$65.4M
$568.2M
Q1 25
$49.9M
$594.1M
Q4 24
$49.5M
$620.8M
Q3 24
$73.7M
$633.2M
Total Debt
BCPC
BCPC
IEX
IEX
Q2 26
Q1 26
Q4 25
$1.8B
Q3 25
$1.9B
Q2 25
$1.9B
Q1 25
$2.0B
Q4 24
$2.0B
Q3 24
$2.1B
Stockholders' Equity
BCPC
BCPC
IEX
IEX
Q2 26
$4.0B
Q1 26
$1.3B
$4.0B
Q4 25
$1.3B
$4.0B
Q3 25
$1.3B
$4.0B
Q2 25
$1.3B
$4.0B
Q1 25
$1.2B
$3.9B
Q4 24
$1.1B
$3.8B
Q3 24
$1.2B
$3.8B
Total Assets
BCPC
BCPC
IEX
IEX
Q2 26
$6.9B
Q1 26
$1.7B
$6.9B
Q4 25
$1.7B
$6.9B
Q3 25
$1.7B
$7.0B
Q2 25
$1.7B
$6.9B
Q1 25
$1.6B
$6.8B
Q4 24
$1.6B
$6.7B
Q3 24
$1.6B
$7.0B
Debt / Equity
BCPC
BCPC
IEX
IEX
Q2 26
Q1 26
Q4 25
0.45×
Q3 25
0.48×
Q2 25
0.46×
Q1 25
0.50×
Q4 24
0.52×
Q3 24
0.55×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BCPC
BCPC
IEX
IEX
Operating Cash FlowLast quarter
$40.1M
Free Cash FlowOCF − Capex
$33.8M
$86.0M
FCF MarginFCF / Revenue
12.5%
21.6%
Capex IntensityCapex / Revenue
2.3%
4.4%
Cash ConversionOCF / Net Profit
0.99×
TTM Free Cash FlowTrailing 4 quarters
$654.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BCPC
BCPC
IEX
IEX
Q2 26
Q1 26
$40.1M
Q4 25
$67.3M
$209.5M
Q3 25
$65.6M
$203.5M
Q2 25
$47.3M
$161.7M
Q1 25
$36.5M
$105.7M
Q4 24
$52.3M
$172.6M
Q3 24
$51.3M
$205.3M
Free Cash Flow
BCPC
BCPC
IEX
IEX
Q2 26
$86.0M
Q1 26
$33.8M
$189.8M
Q4 25
$189.8M
Q3 25
$188.7M
Q2 25
$146.9M
Q1 25
$91.4M
Q4 24
$157.1M
Q3 24
$191.6M
FCF Margin
BCPC
BCPC
IEX
IEX
Q2 26
21.6%
Q1 26
12.5%
46.6%
Q4 25
21.1%
Q3 25
21.5%
Q2 25
17.0%
Q1 25
11.2%
Q4 24
18.2%
Q3 24
24.0%
Capex Intensity
BCPC
BCPC
IEX
IEX
Q2 26
4.4%
Q1 26
2.3%
15.6%
Q4 25
2.2%
Q3 25
1.7%
Q2 25
1.7%
Q1 25
1.8%
Q4 24
1.8%
Q3 24
1.7%
Cash Conversion
BCPC
BCPC
IEX
IEX
Q2 26
Q1 26
0.99×
Q4 25
1.72×
1.63×
Q3 25
1.63×
1.59×
Q2 25
1.23×
1.23×
Q1 25
0.98×
1.11×
Q4 24
1.56×
1.40×
Q3 24
1.52×
1.72×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons